Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100507477 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCDC57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PEX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DCT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507165 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA6D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130938 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLGAP4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HPYR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDFIC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAPRT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01231 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBLC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLRX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IHH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on